Your browser doesn't support javascript.
loading
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional study.
Dousset, Léa; Pacaud, Alize; Barnetche, Thomas; Kostine, Marie; Dutriaux, Caroline; Pham-Ledard, Anne; Beylot-Barry, Marie; Gérard, Emilie; Prey, Sorilla; Andreu, Nicolas; Boniface, Katia; Seneschal, Julien.
Affiliation
  • Dousset L; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Pacaud A; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Barnetche T; Department of Rheumatology, National Reference Center for Severe Systemic Autoimmune Diseases, FHU ACRONIM, Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Kostine M; Department of Rheumatology, National Reference Center for Severe Systemic Autoimmune Diseases, FHU ACRONIM, Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France.
  • Dutriaux C; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Pham-Ledard A; U1035 INSERM, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Bordeaux University, Bordeaux, France.
  • Beylot-Barry M; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Gérard E; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Prey S; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Andreu N; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
  • Boniface K; U1035 INSERM, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Bordeaux University, Bordeaux, France.
  • Seneschal J; Department of Dermatology, National Centre for Rare Skin Disorders, University Hospital of Bordeaux, Bordeaux, France.
JAAD Int ; 5: 112-120, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34712997

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: JAAD Int Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: JAAD Int Year: 2021 Document type: Article Affiliation country: Country of publication: